XRAY
DENTSPLY SIRONA Inc.
NASDAQ · USHealthcareMedical - Instruments & Supplies
$13.46-4.20%
Price as of Jul 20, 2026
XRAY financials
DENTSPLY SIRONA Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $3.7B | $3.8B | $4.0B | $3.9B |
| Cost of revenue | $1.8B | $1.8B | $1.9B | $1.8B |
| Gross profit | $1.8B | $2.0B | $2.1B | $2.1B |
| Operating expenses | $1.6B | $2.8B | $2.2B | $3.1B |
| Operating income | $252.0M | -$879.0M | -$85.0M | -$937.0M |
| Net income | -$598.0M | -$910.0M | -$132.0M | -$950.0M |
| EBITDA | -$46.0M | -$518.0M | $249.0M | -$662.0M |
| Basic EPS | $-3.00 | $-4.48 | $-0.62 | $-4.41 |
| Diluted EPS | $-3.00 | $-4.48 | $-0.62 | $-4.41 |
| Balance sheet | ||||
| Cash & equivalents | $326.0M | $272.0M | $334.0M | $365.0M |
| Total assets | $5.4B | $5.8B | $7.4B | $7.6B |
| Total liabilities | $4.1B | $3.8B | $4.1B | $3.8B |
| Stockholders’ equity | $1.3B | $1.9B | $3.3B | $3.8B |
| Total debt | $2.5B | $2.3B | $2.3B | $2.1B |
| Net debt | $2.1B | $2.0B | $2.0B | $1.8B |
| Cash flow | ||||
| Operating cash flow | $235.0M | $461.0M | $377.0M | $517.0M |
| Capital expenditure | -$131.0M | -$180.0M | -$149.0M | -$149.0M |
| Free cash flow | $104.0M | $281.0M | $228.0M | $368.0M |
| Dividends paid | -$128.0M | -$126.0M | -$116.0M | -$104.0M |
| Share repurchases | $0.00 | -$250.0M | -$300.0M | -$150.0M |